Condition
Hypotonia
Total Trials
6
Recruiting
1
Active
1
Completed
4
Success Rate
80.0%-7% vs avg
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
80.0%
-6.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
2 of 4 completed with results
Key Signals
2 with results80% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Completed4
Terminated1
Recruiting1
Trial Success Rate
80.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT03852004Not ApplicableTerminatedPrimary
Osteopathic Treatment on Motor Development of Hypotonic Infants.
NCT03492060Recruiting
Longitudinal Study of Neurogenetic Disorders
NCT03548779Not ApplicableCompleted
North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2
NCT04846400Not ApplicableCompleted
Pilot Study of a Self-Supporting Nasopharyngeal Airway in Hypotonia
NCT05391594Not ApplicableCompleted
Effect of Trunk Support on Academic Engagement of Children With Severe Disability
NCT04894799Not ApplicableCompleted
Vestibular Stimulation and Neurodevelopmental Technique on Hypotonic Cerebral Palsy While Controlling the Gender
Showing all 6 trials